Approximately 72 and 69% of women who harbor BRCA1 or BRCA2 gene mutations, respectively, are likely to develop breast cancer by the age of 80, equating to a 5–20 fold increased risk of developing breast cancer due to the loss of genetic fidelity in other tumour suppressor genes [13,14]. The gene discussed is BRCA2; the disease is breast carcinoma.